Tailin Biotech: Announcement on passively diluting the shareholding ratio of controlling shareholders, actual controllers, and their co-actors by more than 1%
Tailin Biotech: Announcement on passively diluting the shareholding ratio of controlling shareholders, actual controllers, and their co-actors by more than 1%
Tailin Biotech: Simplified Equity Change Report
Tailin Biotech: An indicative announcement on the cumulative percentage of changes in the rights and interests of controlling shareholders, actual controllers, and their concerted actors to reach 5%
Tailin Biotech: Announcement on passively diluting the shareholding ratio of controlling shareholders, actual controllers, and their co-actors by more than 1%
Tailin Biotech: Announcement on passively diluting the shareholding ratio of controlling shareholders, actual controllers, and their co-actors by more than 1%
Tailin Biotech: Announcement on passively diluting the shareholding ratio of controlling shareholders, actual controllers, and their co-actors by more than 1%
Tailin Biotech: Announcement on early termination of the holdings reduction plan and results for shareholders, some directors and senior management holding 5% or more of the company\'s shares
TAILIN: Pre-disclosure announcement regarding some directors and senior management personnel of the company's shareholding reduction.
TAILIN: Announcement of pre-disclosure of shareholding by shareholders holding more than 5% of shares who plan to reduce their holdings.
TAILIN: Announcement on changes in the rights and interests of controlling shareholders, actual controllers, and their concerted actors to reach 1%
TAILIN: 2023 Equity Distribution Implementation Notice
Tailin Biotech: Announcement on the 2023 Profit Distribution Plan
Tailin Biotech: Announcement on the expiration of the holdings reduction plan for shareholders holding 5% or more and the implementation results of the holdings reduction plan
Tailin Biotech: Pre-disclosure announcement on shareholders holding 5% or more of the shares to reduce their shareholding
Tailin Biotech: Announcement on the price adjustment of Tailin\'s debt-to-equity conversion
Tailin Biotech: Announcement on the results of the first vesting period granted by the 2022 Restricted Stock Incentive Plan for the first time and the listing of shares
Tailin Biotech: Announcement on scrapping part of the 2022 Restricted Stock Incentive Plan that has been granted restricted stocks that have not yet been attributed
Tailin Biotech: The Supervisory Board\'s Verification Opinion on the 2022 Restricted Stock Incentive Plan for the First Grant of a Part of the Vesting List for the First Vesting Period
Tailin Biotech: Announcement on the 2022 Restricted Stock Incentive Plan for the first time awarding some of the vesting conditions for the first vesting period